HIF1A and neoplasm: Chen et al., (2020) has reported that upregulation of HIF1α was found to be associated with activation of other oncogenic pathways like anti-tumor immunosuppression, cell cycle, EMT etc. This association has showed tumor promoter role of HIF1α [22].